There is evidence that smoking-cessation success differs by menstrual phase and sex hormone levels; however, the biological mechanisms underlying these differences are not clear. One possibility is that variation in cortisol throughout the menstrual cycle and early smoking abstinence may be partly responsible. The goal of this secondary-data analysis was to conduct a within-subject examination of the effects of menstrual phase and smoking abstinence on salivary cortisol and mood. Data are from a controlled crossover trial, in which participants completed 2 testing weeks during their follicular and luteal phases. During each testing week, they smoked ad libitum during the first 2 days and then abstained from smoking during the next 4 days. Salivary cortisol and self-reported mood were collected 5 times on the day before abstinence (D0) and the first (D1) and third (D3) days of abstinence. Participants (n ϭ 125) were, on average (mean Ϯ SE), 29.4 Ϯ 0.6 years old and smoked 12.6 Ϯ 0.5 cigarettes/day. Whereas salivary cortisol varied significantly by time of day (p Ͻ .0001) and smoking abstinence (D0 to D1: ␤ ϭ Ϫ0.06 Ϯ 0.02 log[ng/ml], p ϭ .0074 and D3: ␤ ϭ Ϫ0.05 Ϯ 0.02 log[ng/ml], p ϭ .0117). no significant differences by menstrual phase were observed. Craving increased from D0 to D1 during the follicular phase but decreased in the luteal phase (ϩ0.31 vs. Ϫ0.15, ␤ ϭ 0.46 Ϯ 0.19, p ϭ .0162). This work builds on prior observations in demonstrating a decrease in cortisol in acute smoking abstinence and menstrual phase differences in craving. The results provide further evidence that cortisol levels do not vary by menstrual phase in the first few days of abstinence.
Smoking cessation efforts in premenopausal women are influenced by sex hormones. Specifically, progesterone protects against drug taking behaviors, whereas estrogen facilitates these behaviors (Carroll & Anker, 2010; Lynch & Sofuoglu, 2010) . A recent meta-analysis has identified menstrual phase (used as a proxy for sex hormones) as a significant predictor of withdrawal (Weinberger et al., 2015) , although evidence implicating menstrual phase and sex hormones (i.e., progesterone and estrogen) as predictors of smoking relapse remains mixed. One randomized controlled pilot trial on using exogenous progesterone to prevent smoking relapse among postpartum women saw lower relapse rates in the progesterone group compared to the placebo group (although not statistically significantly different; Allen, Allen, Lunos, & Tosun, 2016) . Some studies have found that quitting smoking in the follicular phase (when estrogen and progesterone levels are both low) leads to better outcomes (Carpenter, Saladin, Leinbach, Larowe, & Upadhyaya, 2008; Franklin et al., 2008) , whereas others have reported quitting in the luteal phase (when progesterone levels are high) as more favorable (Allen, Bade, Center, Finstad, & Hatsukami, 2008; Mazure, Toll, McKee, Wu, & O'Malley, 2011) ; and yet others have observed no differences in relapse rates by menstrual phase (Epperson et al., 2010) . However, the specific biological mechanisms through which menstrual phase might affect smoking-related outcomes remain unknown, and multiple possibilities (including hormonal response to stress) should be explored. Better understanding of these mechanisms could help disentangle the mixed results published in the literature and inform novel smoking cessation interventions.
One possible mechanism of action responsible for differing smoking-related outcomes by menstrual phase is the physiological response to stress. A commonly studied biological indicator of physiological stress response is salivary cortisol, which is produced by activity in the hypothalamic-pituitary adrenal axis (HPA) (al 'Absi, 2006) . Increases in cortisol levels after exposure to a stressor are larger for situations characterized by lack of control, uncertainty, and anticipation of aversive events (al 'Absi, 2006; Lovallo, Pincomb, Brackett, & Wilson, 1990) . There is evidence that cortisol might differ by menstrual phase because there are a few small studies that have found higher cortisol levels (but not statistically significant differences) in the luteal phase compared with the follicular phase (Andreano, Arjomandi, & Cahill, 2008; Walder, Statucka, Daly, Axen, & Haber, 2012) , but inconsistencies are evident in the literature. For example, we previously observed no variation in salivary cortisol by menstrual phase (Allen, Allen, Widenmier, & al'Absi, 2009 ), but Wolfram, Bellingrath, and Kudielka (2011) found that the cortisol-awakening response was significantly elevated during ovulation, and Duchesne and Pruessner (2013) saw differences in the association between cortisol and subjective stress by menstrual phase. These results suggest that sex hormones may modulate the cortisol stress response.
There is also evidence that changes in salivary cortisol are associated with smoking and acute smoking abstinence. Several studies have found that cortisol decreases in early smoking abstinence Ussher et al., 2006; Wong, Pickworth, Waters, al'Absi, & Leventhal, 2014) and that this early cortisol response may be a predictor of smoking relapse for men alone (al'Absi, 2006) and for both men and women together (Rasmusson, Wu, Paliwal, Anderson, & Krishnan-Sarin, 2006; Ussher et al., 2006) . However, this association is less clear for women alone. Additionally, prior studies have found that smoking leads to blunted hormonal responses to stress (al'Absi, Wittmers, Erickson, Hatsukami, & Crouse, 2003; Back et al., 2008; Buchmann et al., 2010; Ginty et al., 2014; Kumari et al., 2010; Rohleder & Kirschbaum, 2006; Wardle, Munafò, & de Wit, 2011) . For example, one study of 480 male and female participants found that current smokers had significantly lower cortisol reactions to an acute stressor compared with ex-and never smokers (Ginty et al., 2014) . This suggests smoking may lead to a chronic dysregulation of the stress-response system or it is possible that nicotine somehow mediates the HPA activity.
Given that cortisol may differ by menstrual phase, and cortisol may be associated with smoking and smoking abstinence, the variance in smoking-related outcomes by menstrual phase could be related to differences in cortisol. On the other hand, self-reported mood (which might also vary by phase) is a strong predictor of smoking relapse in women and may be playing a role as well (al'Absi, 2006; Nakajima & al'Absi, 2012) . For example, women may report more withdrawal and perceived stress in the luteal phase compared to the follicular phase (Allen et al., 2014) . On the other hand, although other literature suggests the relationships between daily mood and sex hormones in women without mood disorders are inconsistent (Schwartz, Romans, Meiyappan, De Souza, & Einstein, 2012; Ziomkiewicz et al., 2012) , mood is consistently predictive of smoking relapse (al'Absi, Hatsukami, Davis, & Wittmers, 2004; Allen, al'Absi, Lando, Hatsukami, & Allen, 2013) . Because mood is a subjective and self-reported measure, and cortisol is a physiological objective measure of stress response, understanding cortisol's association with smoking and smoking abstinence could help inform more objective cessation plans for smoking women. For instance, Goldberg et al. (2014) used hair cortisol levels as a novel objective biomarker in a cessation study. They found a correlation between the reduced hair cortisol and reduced negative affect during smoking cessation treatment and mindfulness training (Goldberg et al., 2014) .
To date, the intersection between menstrual phase, smoking abstinence, mood, and salivary cortisol remains largely unexplored. Most studies published on cortisol and the menstrual phase are limited by small homogenous samples and between-subjects comparisons, which limits the statistical power to identify significant differences. We have not yet studied menstrual phase differences in cortisol, although we have studied menstrual phase differences in nicotine response (Huttlin, Allen, Tosun, Allen, & al'Absi, 2015) , smoking-related symptomatology (Allen et al., 2014) allopregnanolone, and depressive symptoms (Allen, al'Absi, Lando, Hatsukami, & Allen, 2013; Allen et al., 2014) . Thus, the goals of the present secondary-data analysis were to conduct a within-subject comparison of (a) the change in cortisol and mood from follicular to luteal menstrual phases, (b) the change in cortisol and mood from ad libitum smoking to acute abstinence, and (c) to test for menstrual phase differences in the change in cortisol and mood from ad libitum smoking to acute abstinence. It was expected that cortisol and positive mood would decrease from ad libitum smoking to acute abstinence and increase from follicular to luteal phase and that the decrease in cortisol and positive mood from ad libitum smoking to abstinence would vary by menstrual phase. Specifically, because some research suggests the luteal phase has been a more favorable phase for smoking abstinence, it This document is copyrighted by the American Psychological Association or one of its allied publishers.
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was hypothesized that the decrease in cortisol and positive mood from ad libitum smoking to acute abstinence would be smaller in the luteal phase than the follicular phase.
Method Study Sample
The data for this analysis are from a parent study designed to examine the effect of depressive symptoms and menstrual phase on smoking-related and menstrual-related symptomatology during acute smoking abstinence (Allen et al., 2014) . This study used social and mass media advertising to enroll women smokers between the ages of 18 and 40 years who were not currently interested in quitting smoking permanently into a controlled crossover study. Participants had to smoke at least five cigarettes per day for at least the past 6 months, have regular menstrual cycles, and be in stable physical and mental health. Excessive alcohol use (Ͼ7 drinks three times per week) or other drug use (more than two times per month), use of exogenous hormones, psychotropic medications, other forms of nicotine or tobacco, or cessation products was exclusionary. Additional details on recruitment and study procedures have been published elsewhere (Allen et al., 2014) . Participants were included in this analysis only if they had at least one cortisol measurement, hormone levels consistent with their assigned menstrual phase (luteal phase: progesterone Ͼ2 ng/ml and follicular phase: progesterone Յ2 ng/ml), and biochemically confirmed smoking abstinence in accordance with the study protocol. Abstinence was biologically verified with carbon monoxide breathalyzer (Ͻ5 ppm, indicating abstinence; Perkins, Karelitz, & Jao, 2013) and salivary cotinine (Ͻ15 ng/ml, indicating abstinence on the fourth day of abstinence; Benowitz et al., 2002) .
Study Protocol
All participants completed 2 identical testing weeks. Upon study enrollment, participants were randomly assigned to testing orderfollicular phase (2-7 days after the self-reported onset of menses) and then the luteal phase (2-7 days after luteinizing hormone surge) or vice versa. Each testing week consisted of 2 days of ad libitum smoking followed by 4 days of smoking abstinence. Participants attended daily clinic visits to biochemically confirm smoking status and provide a blood sample for hormone (progesterone, estrogen) measurement. Salivary cortisol was collected at home on 3 days-the day before abstinence (D0: during ad libitum smoking), the first day of abstinence (D1), and the third day of abstinence (D3). To increase compliance, participants were provided with paper forms and collection materials labeled with the collection date and time and received a bonus payment if they missed Յ1 saliva samples each week. Each day of salivary cortisol collection consisted of five time points-upon waking, 30 min after waking, 2 hours after waking, 8 p.m., and before bed. Saliva samples were self-collected with saliva sample swabs (Salivette ® tubes; Sarstedt, Rommelsdorf, Germany). Participants were instructed to place the swab in their mouth for 5 minutes to collect approximately 2 ml of saliva. The swab was then placed in a plastic tube and stored at room temperature until returned to the clinic the next day. While collecting the saliva samples, participants completed a pencil-and-paper form to collect relevant confounder information. At two time points each day (at waking and 8 p.m.), participants also filled out a survey reporting their mood. Upon completion of the first testing week, participants resumed ad libitum smoking for approximately 6 weeks until they arrived at the alternate menstrual phase, and then the same procedures were completed again. All study procedures were approved by the University of Minnesota Institutional Review Board.
Measures
Our predictor variables for this project were acute smoking abstinence (D0 vs. D1; and D0 vs. D3) and menstrual phase (follicular phase vs. luteal phase). As noted above, abstinence was biologically verified using CO and cotinine, and menstrual phase was prospectively determined by self-reported onset of menses and urinary luteinizing hormone results (which precedes ovulation by 24 -48 hours and the subsequent luteal phase). Our outcome variables were salivary cortisol and self-reported mood. Cortisol assays were measured in duplicate with time-resolved immunoassay fluorometric end point detection as previously described Dressendörfer, Kirschbaum, Rohde, Stahl, & Strasburger, 1992) . Mood was measured outside of the clinic twice daily (upon waking and at 8 p.m.) via the Subjective State Scale (SSS; al'Absi, Hatsukami, Davis, & Wittmers, 2004; al'Absi, Wittmers, Erickson, Hatsukami, Crouse 2003) . The SSS consists of 24 items rated on a Likert-type scale from 0 (not at all) to 7 (very strong). Items are organized into five subscales (craving, withdrawal, physical symptoms, positive affect, and negative affect), and the item scores within each subscale are averaged. Other covariates assessed included time of day (upon waking, 30 min after waking, 2 hours after waking, 8 p.m., and before bed), race, depressive symptoms (at baseline via the Center for Epidemiologic Study-Depression Scale; range 0 -60, with scores Ն16 indicating at risk for clinical depression; Radloff, 1977) , as well as any of the following occurring in the hour prior to cortisol collection: food intake, smoking, caffeine intake, alcohol intake, exercise, or a significant event (e.g., argument with friend, stress at work, wedding).
Statistical Analysis
Descriptive statistics were calculated for demographics, smoking behavior variables, and cortisol and mood levels. Cortisol and mood levels were assessed for normality using histograms and QQ plots by phase. Cortisol, physical symptoms, withdrawal, and negative affect had positively skewed distributions and were logged transformed prior to analysis to comply with the assumptions of linear mixed modeling (random patterned residuals and normal distribution of the outcome). Because mood variables had some scores equal to 0, 1 was added to the score prior to logtransforming. The results are reported as means and standard errors on the log scale or back-transformed geometric means and 95% confidence intervals. The other two outcomes, positive affect and craving, were normally distributed and analyzed without log transformation. Cortisol levels Ͼ50 ng/ml at 8 p.m. or before bed were excluded as outliers (n ϭ 4 samples). The associations between categorical predictors (menstrual phase, smoking abstinence) and continuous outcomes (cortisol, mood subscales on the SSS) were assessed using linear mixed models with PROC MIXED in SAS This document is copyrighted by the American Psychological Association or one of its allied publishers.
Software version 9.4 (SAS Institute Inc., Cary, NC). To account for repeated measures (two mood measures per day and five cortisol measures per day), models contained a repeated statement for [Menstrual Phase ϫ Time of Day ϫ Smoking Abstinence] with a heterogeneous compound symmetry correlation structure. A main-effects model as well as a model testing for an interaction between menstrual phase and smoking abstinence were run for cortisol and each mood outcome. Possible covariates were evaluated by adding each covariate to the main effects model independently. Covariates that were statistically associated (p Ͻ .05) with cortisol or at least one mood outcome were included in the adjusted models. The adjusted models for cortisol included race, depressive symptoms, food intake, and caffeine intake. The adjusted models for mood outcomes included race, depressive symptoms, food intake, caffeine intake, a recent significant event, and alcohol intake. p values were not adjusted for multiple tests, using a cutoff of p ϭ .05 for significance.
Results

Study Sample
As described in detail elsewhere (Allen et al., 2014) , a total of 207 participants were enrolled into the study. After dropouts (n ϭ 47) and exclusions (smoking during abstinence period (n ϭ 9), inconsistency between serum hormone levels and menstrual phase (n ϭ 4), missing/outliers for cortisol data (n ϭ 22), a total of 125 participants had hormone levels were indicative of correct testing phase and normal cycling. Thus, our final sample size was 125. Overall, participants were (mean Ϯ SE) 29.4 Ϯ 0.6 years old and were fairly racially diverse with approximately 41% identifying as non-White. They smoked an average of 12.6 Ϯ 0.5 cigarettes per day and had an average Center for Epidemiologic Study-Depression score of 13.0 Ϯ 0.4 (22%, 27 of 123 scored 16 or higher, at risk for clinical depression). (see Table 1 ).
Salivary Cortisol
Salivary cortisol was, on average (geometric mean, 95% confidence interval), 6.98 [6.49 -7.51] ng/ml on D0, 6.60 [6.12-7.13] ng/ml on D1, and 6.62 [6.12-7.16] ng/ml on D3. First morning cortisol measure was 9.04 [8.46 -9.65] ng/ml, 30 min after waking was 10.44 [9.71-11.24 ] ng/ml, 2 hours after waking was 7.14 [6.66, 7.66] ng/ml, the 8 p.m. measure was 4.43 [4.04 -4.86] ng/ml, and the last measure before bed was 4.61 [4.18 -5.08] ng/ml. On average (all days and time points), cortisol was 6.78 [6.28 -7.32 ] ng/ml in the follicular phase and 6.68 [6.21-7.19 ] ng/ml in the luteal phase. Salivary cortisol varied significantly by smoking abstinence (see Table 2 ). Compared with D0, cortisol was lower on D1 (␤ ϭ Ϫ0.06 Ϯ 0.02 log[ng/ml], p ϭ .0074) and D3 (␤ ϭ Ϫ0.05 Ϯ 0.02 log[ng/ml], p ϭ .0117). Cortisol levels increased from waking to 30 min after waking (␤ ϭ 0.14 Ϯ 0.02 log[ng/ml], p Ͻ .0001) and then decreased throughout the rest of the day as expected (␤'s ϭ Ϫ0.24 Ϯ 0.02, Ϫ0.71 Ϯ 0.03, Ϫ0.67 Ϯ 0.03 log[ng/ml], all changes p Ͻ .0001). There were no statistically significant menstrual phase differences in cortisol values, and the change in cortisol from D0 to D1 and D3 did not vary by menstrual phase. The overall F test statistics are reported in Table 2 .
Mood
We noted two statistically significant relationships in mood and smoking-related symptomatology measures (see Table 2 ). First, log-transformed negative affect was higher on D3 compared with D0 (␤ ϭ 0.05 Ϯ 0.02, p ϭ .0444). Second, during the follicular phase, there was an increase in craving from D0 to D1, whereas there was a decrease in the luteal phase (ϩ0.31 vs. Ϫ0.15, ␤ ϭ 0.46 Ϯ 0.19, p ϭ .0162). No significant differences in any of the five mood subscales were observed by menstrual phase or smoking abstinence, and there were no other significant interactions between menstrual phase and smoking abstinence for mood outcomes.
Discussion
This secondary data analysis from a controlled crossover study examined within-subject changes in salivary cortisol by menstrual phase during acute smoking abstinence. Whereas the menstrual phase was not related to salivary cortisol levels or the change in salivary cortisol during acute smoking abstinence, acute smoking abstinence was associated with reduced cortisol concentrations as expected based on prior literature Ussher et al., 2006; Wong, Pickworth, Waters, al'Absi, & Leventhal, 2014) . The reason for this decrease is not yet known; however, a few ideas were presented by Wong, Pickworth, Waters, al'Absi, and Leventhal (2014) , such as nicotine's mediation of the HPA activity or biological adaptations due to dampened HPA activity because of smoking. Consistent with prior findings , most of the subjective report of mood did not vary by menstrual phase with the exception of a greater increase in cigarette craving from the day before abstinence to the first day of abstinence during the follicular phase compared to the luteal phase. Lastly, regardless of menstrual phase, we saw a significant in- This document is copyrighted by the American Psychological Association or one of its allied publishers. This article is intended solely for the personal use of the individual user and is not to be disseminated broadly. This article is intended solely for the personal use of the individual user and is not to be disseminated broadly.
crease in negative affect during smoking abstinence, which is also consistent with the literature (Abrantes et al., 2008) .
In both the present study and our prior work we did not observe a menstrual phase difference in salivary cortisol despite several methodological differences including different study samples (e.g., participants who wanted to quit smoking permanently vs. those who did not) and study designs (e.g., a between-subjects comparison in a randomized control trial vs. a within-subject comparison in a controlled crossover study; Allen et al., 2009) . In previously published work, in this same sample of women, we observed significantly higher perceived stress in the luteal phase compared with the follicular phase during acute smoking abstinence (Allen et al., 2014) . Thus, it is interesting that although perceived stress was different by phase and cortisol is a physiological response to stress, we did not see differences in cortisol by phase. This may suggest that even though women feel more stress when abstaining from cigarettes during the luteal phase as compared with the follicular phase, their cortisol levels are not responding to this increased stress. One possible explanation for this contradiction is that smoking leads to blunted hormonal responses to stress in women (al'Absi, Wittmers, Erickson, Hatsukami, & Crouse, 2003; Back et al., 2008; Kumari et al., 2010; Rohleder & Kirschbaum, 2006) . Consequently, the cortisol response to stress may be blunted by smoking throughout both phases, causing the levels to be fairly consistent. Given the consistency in observations, it seems that cortisol is likely not the biological mechanism responsible for the influence of menstrual phase on smoking-cessation outcomes.
The greater increase in cigarette craving from the day before abstinence to the first day of abstinence during the follicular phase versus the luteal phase is an intriguing observation. This finding is supported by one of our prior studies in which women reported significantly higher craving levels in the morning (on the day before abstinence) during the follicular phase as compared with the luteal phase ). In our study, by the third day of abstinence, craving levels were similar between menstrual phases. This suggests that craving peaks earlier during smoking abstinence in the follicular phase as compared with the luteal phase, which could be related to the protective effects of higher progesterone levels on smoking-related symptomatology in the luteal phase that are not present in the follicular phase (Sofuoglu, Mitchell, & Mooney, 2009 ). When we compared craving levels by menstrual phase utilizing data that were collected at clinic visits (rather than in the participants' natural environment as we did in this project), there were no significant differences by menstrual phase (Allen et al., 2014) . These projects utilized data from the same study samples but collected at different times and places (e.g., at home vs. clinic visits). The reason for these differences is unknown, but future research could examine different methodologies for craving measurement, exploring reasons for variation in the craving levels reported.
Whereas this project offers several strengths, it also has limitations. First, selection bias was likely present given we enrolled participants who did not want to quit smoking and who were able to comply with a rigorous daily clinic schedule. Thus, our observations may not be generalizable to women who are attempting to quit smoking permanently. It is possible that mood, cortisol, and other variables would be different for women attempting to quit smoking long-term compared with the women in our study who knew they were only refraining from smoking for 4 days. Second, participants collected saliva samples and completed mood questionnaires outside the clinic. Whereas the observed significant differences in diurnal variation of cortisol suggest participants complied with the protocol, there is no way to confirm this. Despite these limitations, this project extends the current literature by being the first within-subject comparison of menstrual phase and acute smoking abstinence effects on salivary cortisol and mood.
In conclusion, menstrual phase in smoking women may influence craving during acute smoking abstinence but does not appear to influence salivary cortisol. Future work should evaluate other possible mechanisms responsible for the differences in the influence of menstrual cycle on smoking cessation outcomes, such as craving, withdrawal, premenstrual symptoms, or nicotine replacement therapy (Franklin & Allen, 2009 ). Understanding these biological mechanisms could help inform more targeted cessation interventions for women.
